Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation

Human Molecular Genetics

Volumn 20, Issue 17, 2011, Pages 3450-3460

  Reynard, Louise N ^a   Bui, Catherine ^a   Canty laird, Elizabeth G ^b   Young, David A ^a   Loughlin, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GDF5 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOARTHRITIS; PENETRANCE; PRIORITY JOURNAL; PROMOTER REGION; UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; CELL LINE; CELL LINE, TUMOR; DNA METHYLATION; GENETIC PREDISPOSITION TO DISEASE; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; OSTEOARTHRITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80051693596     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr253     Document Type: Article

References (52)

1. World Health Organization Scientific Group. (2003) The burden of musculoskeletal conditions at the start of the new millennium: report of a WHO Scientific Group. World Health Organization, Geneva, Switzerland.
2. Miyamoto, Y., Mabuchi, A., Shi, D., Kubo, T., Takatori, Y., Saito, S., Fujioka, M., Sudo, A., Uchida, A., Yamamoto, S. et al. (2007) A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet., 39, 529-533.
3. Chapman, K., Takahashi, A., Meulenbelt, I., Watson, C., Rodriguez-Lopez, J., Egli, R., Tsezou, A., Malizos, K.N., Kloppenburg, M., Shi, D. et al. (2008) A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum. Mol. Genet., 17, 1497-1504.
4. Evangelou, E., Chapman, K., Meulenbelt, I., Karassa, F.B., Loughlin, J., Carr, A., Doherty, M., Doherty, S., Gomez-Reino, J.J., Gonzalez, A. et al. (2009) Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum., 60, 1710-1721.
5. Ji, J., Dai, J., Shi, D. and Jiang, Q. (2010) Association of genetic and mechanical factors with age of onset of knee osteoarthritis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 27, 672-674.
6. Southam, L., Rodriguez-Lopez, J., Wilkins, J.M., Pombo-Suarez, M., Snelling, S., Gomez-Reino, J.J., Chapman, K., Gonzalez, A. and Loughlin, J. (2007) An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum. Mol. Genet., 16, 2226-2232.
7. Vaes, R.B., Rivadeneira, F., Kerkhof, J.M., Hofman, A., Pols, H.A., Uitterlinden, A.G. and van Meurs, J.B. (2009) Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study. Ann. Rheum. Dis., 68, 1754-1760.
8. Valdes, A.M., Evangelou, E., Kerkhof, H.J., Tamm, A., Doherty, S.A., Kisand, K., Kerna, I., Uitterlinden, A., Hofman, A., Rivadeneira, F. et al. (2011) The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann. Rheum. Dis., 70, 873-875.
9. Valdes, A.M., McWilliams, D., Arden, N.K., Doherty, S.A., Wheeler, M., Muir, K.R., Zhang, W., Cooper, C., Maciewicz, R.A. and Doherty, M. (2010) Involvement of different risk factors in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes. Arthritis Rheum., 62, 2688-2695.
10. Luyten, F.P. (1997) Cartilage-derived morphogenetic protein-1. Int. J. Biochem. Cell Biol., 29, 1241-1244.
11. Buxton, P., Edwards, C., Archer, C.W. and Francis-West, P. (2001) Growth/Differentiation Factor-5 (GDF-5) and Skeletal Development. J. Bone. Joint. Surg. Am., 83, S23-S30.
12. Francis-West, P.H., Abdelfattah, A., Chen, P., Allen, C., Parish, J., Ladher, R., Allen, S., MacPherson, S., Luyten, F.P. and Archer, C.W. (1999) Mechanisms of GDF-5 action during skeletal development. Development, 126, 1305-1315.
13. Nakamura, K., Shirai, T., Morishita, S., Uchida, S., Saeki-Miura, K. and Makishima, F. (1999) p38 Mitogen-Activated Protein Kinase Functionally Contributes to Chondrogenesis Induced by Growth/Differentiation Factor-5 in ATDC5 Cells. Exp. Cell Res., 250, 351-363.
14. Settle, J.S.H., Rountree, R.B., Sinha, A., Thacker, A., Higgins, K. and Kingsley, D.M. (2003) Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol., 254, 116-130.
15. Thomas, J.T., Lin, K., Nandedkar, M., Camargo, M., Cervenka, J. and Luyten, F.P. (1996) A human chondrodysplasia due to a mutation in a TGF-beta superfamily member. Nat. Genet., 12, 315-317.
16. Thomas, J.T., Kilpatrick, M.W., Lin, K., Erlacher, L., Lembessis, P., Costa, T., Tsipouras, P. and Luyten, F.P. (1997) Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet., 17, 58-64.
17. Seemann, P., Schwappacher, R., Kjaer, K.W., Krakow, D., Lehmann, K., Dawson, K., Stricker, S., Pohl, J., Ploger, F., Staub, E. et al. (2005) Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J. Clin. Invest., 115, 2373-2381.
18. Polinkovsky, A., Robin, N.H., Thomas, J.T., Irons, M., Lynn, A., Goodman, F.R., Reardon, W., Kant, S.G., Brunner, H.G., van der Burgt, I. et al. (1997) Mutations in CDMP1 cause autosomal dominant brachydactyly type C. Nat. Genet., 17, 18-19.
19. Faiyaz-Ul-Haque, M., Ahmad, W., Wahab, A., Haque, S., Azim, A.C., Zaidi, S.H.E., Teebi, A.S., Ahmad, M., Cohn, D.H., Siddique, T. et al. (2002) Frameshift mutation in the cartilage-derived morphogenetic protein 1 (CDMP1) gene and severe acromesomelic chondrodysplasia resembling Grebe-type chondrodysplasia. Am. J. Med. Genet., 111, 31-37.
20. Dai, J., Shi, D., Zhu, P., Qin, J., Ni, H., Xu, Y., Yao, C., Zhu, L., Zhu, H., Zhao, B. et al. (2008) Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res. Ther., 10, R126.
21. Rouault, K., Scotet, V., Autret, S., Gaucher, F., Dubrana, F., Tanguy, D., El Rassi, C.Y., Fenoll, B. and Ferec, C. (2010) Evidence of association between GDF5 polymorphisms and congenital dislocation of the hip in a Caucasian population. Osteoarthritis Cartilage, 18, 1144-1149.
22. Williams, F.M., Popham, M., Hart, D.J., de Schepper, E., Bierma-Zeinstra, S., Hofman, A., Uitterlinden, A.G., Arden, N.K., Cooper, C., Spector, T.D. et al. (2011) GDF5 single-nucleotide polymorphism rs143383 is associated with lumbar disc degeneration in Northern European women. Arthritis Rheum., 63, 708-712.
23. Posthumus, M., Collins, M., Cook, J., Handley, C.J., Ribbans, W.J., Smith, R.K., Schwellnus, M.P. and Raleigh, S.M. (2010) Components of the transforming growth factor-(family and the pathogenesis of human Achilles tendon pathology-a genetic association study. Rheumatology (Oxford), 49, 2090-2097.
24. Posthumus, M., Saunders, C., September, A.V. and Collins, M. (2011) The polygenic profiles in participants with achilles tendinopathy and controls. Br. J. Sports. Med., 45, 369.
25. Egli, R., Southam, L., Wilkins, J.M., Lorenzen, I., Pombo-Suarez, M., Gonzalez, A., Carr, A., Chapman, K. and Loughlin, J. (2009) Functional analysis of the GDF5 regulatory polymorphism that is associated with OA susceptibility. Arthritis Rhuematism, 60, 2055-2064.
26. Lango Allen, H., Estrada, K., Lettre, G., Berndt, S.I., Weedon, M.N., Rivadeneira, F., Willer, C.J., Jackson, A.U., Vedantam, S., Raychaudhuri, S. et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature, 467, 832-838.
27. Sanna, S., Jackson, A.U., Nagaraja, R., Willer, C.J., Chen, W.-M., Bonnycastle, L.L., Shen, H., Timpson, N., Lettre, G., Usala, G. et al. (2008) Common variants in the GDF5-UQCC region are associated with variation in human height. Nat. Genet., 40, 198-203.
28. Harada, M., Takahara, M., Zhe, P., Otsuji, M., Iuchi, Y., Takagi, M. and Ogino, T. (2007) Developmental failure of the intra-articular ligaments in mice with absence of growth differentiation factor 5. Osteoarthritis Cartilage, 15, 468-474.
29. Storm, E.E., Huynh, T.V., Copeland, N.G., Jenkins, N.A., Kingsley, D.M. and Lee, S.J. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature, 368, 639-643.
30. Daans, M., Luyten, F.P. and Lories, R.J.U. (2011) GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann. Rheum. Dis., 70, 208-213.
31. Cheung, K.S., Hashimoto, K., Yamada, N. and Roach, H.I. (2009) Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol. Int., 29, 525-534.
32. da Silva, M.A., Yamada, N., Clarke, N.M. and Roach, H.I. (2009) Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J. Orthop. Res., 27, 593-601.
33. Roach, H.I., Yamada, N., Cheung, K.S., Tilley, S., Clarke, N.M., Oreffo, R.O., Kokubun, S. and Bronner, F. (2005) Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis. Rheum., 52, 3110-3124.
34. Scott, J.L., Gabrielides, C., Davidson, R.K., Swingler, T.E., Clark, I.M., Wallis, G.A., Boot-Handford, R.P., Kirkwood, T.B.L., Talyor, R.W. and Young, D.A. (2010) Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis., 69, 1502-1510.
35. Li, L.-C. and Dahiya, R. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics, 18, 1427-1431.
36. Klug, M. and Rehli, M. (2006) Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics, 1, 127-130.
37. Trinklein, N.D., Aldred, S.J., Saldanha, A.J. and Myers, R.M. (2003) Identification and functional analysis of human transcriptional promoters. Genome Res., 13, 308-312.
38. Weber, M., Hellmann, I., Stadler, M.B., Ramos, L., Paabo, S., Rebhan, M. and Schubeler, D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet., 39, 457-466.
39. Fraga, M.F., Ballestar, E., Paz, M.F., Ropero, S., Setien, F., Ballestar, M.L., Heine-Suñer, D., Cigudosa, J.C., Urioste, M., Benitez, J. et al. (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA, 102, 10604-10609.
40. Gonzalo, S. (2010) Epigenetic alterations in aging. J. Appl. Physiol., 109, 586-597.
41. Kaminsky, Z.A., Tang, T., Wang, S.-C., Ptak, C., Oh, G.H.T., Wong, A.H.C., Feldcamp, L.A., Virtanen, C., Halfvarson, J., Tysk, C. et al. (2009) DNA methylation profiles in monozygotic and dizygotic twins. Nat. Genet., 41, 240-245.
42. Cook, M.B., Chia, V.M., Berndt, S.I., Graubard, B.I., Chanock, S.J., Rubertone, M.V., Erickson, R.L., Hayes, R.B. and McGlynn, K.A. (2011) Genetic contributions to the association between adult height and testicular germ cell tumors. Int. J. Epidemiol. doi: 10.1093/ije/dyq260
43. Bjornsson, H.T., Sigurdsson, M.I., Fallin, M.D., Irizarry, R.A., Aspelund, T., Cui, H., Yu, W., Rongione, M.A., Ekström, T.J., Harris, T.B. et al. (2008) Intra-individual Change Over Time in DNA Methylation With Familial Clustering. JAMA, 299, 2877-2883.
44. Fuke, C., Shimabukuro, M., Petronis, A., Sugimoto, J., Oda, T., Miura, K., Miyazaki, T., Ogura, C., Okazaki, Y. and Jinno, Y. (2004) Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann. Hum. Genet., 68, 196-204.
45. Wilson, V.L. and Jones, P.A. (1983) DNA methylation decreases in aging but not in immortal cells. Science, 220, 1055-1057.
46. Wilson, V.L., Smith, R.A., Ma, S. and Cutler, R.G. (1987) Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem., 262, 9948-9951.
47. Bjornsson, H.T., Daniele Fallin, M. and Feinberg, A.P. (2004) An integrated epigenetic and genetic approach to common human disease. Trends Genet., 20, 350-358.
48. Sesselmann, S., Soder, S., Voigt, R., Haag, J., Grogan, S.P. and Aigner, T. (2009) DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis Cartilage, 17, 507-512.
49. Loeser, R.F., Im, H.J., Richardson, B., Lu, Q. and Chubinskaya, S. (2009) Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage, 17, 513-517.
50. Dodd, A.W., Rodriguez-Fontenla, C., Calaza, M., Carr, A., Gomez-Reino, J.J., Tsezou, A., Reynard, L.N., Gonzalez, A. and Loughlin, J. (2011) Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus. Osteoarthritis Cartilage, 19, 430-434.
51. Bock, C., Reither, S., Mikeska, T., Paulsen, M., Walter, Jr. and Lengauer, T. (2005) BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics, 21, 4067-4068.
52. McKay, J., Waltham, K., Williams, E. and Mathers, J. (2011) Folate depletion during pregnancy and lactation reduces genomic DNA methylation in murine adult offspring. Genes Nutrition, 6, 189-196.